跳至主要内容
临床试验/CTRI/2025/09/093968
CTRI/2025/09/093968
尚未招募
3 期

An Interventional Study to Assess Clinical Relevance of Chapter Constitution From Homoeopathic Medical Repertory By Robin Murphy In Cases of Type 2 Diabetes Mellitus

Dr Renuben Chavda1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月1日最近更新:

概览

阶段
3 期
状态
尚未招募
发起方
Dr Renuben Chavda
入组人数
50
试验地点
1
主要终点
Monarch score

概览

简要总结

The Constitution chapter in the Homoeopathic Medical Repertory By Robin Murphy is important for several reasons in homeopathic case taking and remedy selection. Constitutional analysis involves assessing the overall physical, mental and emotional makeup of a person. This allows a homeopath to go beyond superficial symptoms and find a deeper acting remedy that suits the patient as a whole.

Diabetes Mellitus being a chronic metabolic disease, this chapter will provide rubrics that help to identify deep acting, constitutional remedies.

In this clinical trial, using of two groups (1) Based on totality formation of rubrics from constitutional chapter of Murphy Repertory (2)Based on totality formation of Murphy Repertory

So, my research is based on clinical relevance of rubrics of chapter constitution from Homeopathic Medical Repertory by Robin Murphy for totality formation and remedy selection for patient with type 2 Diabetes Mellitus of age 35 to 70 years in study duration of 9 months.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 70.00 Year(s)(—)

入选标准

  • Diagnosed cases of type 2 Diabetes Mellitus of both sexes will be included.
  • Age/Gender: The cases between 35 to 70 years will be selected irrespective of gender.

排除标准

  • Cases of type 1 Diabetes Mellitus.
  • Patient having diabetic complications (e.g., Nephropathy, Retinopathy) Patient who requires emergency medical treatment.
  • Cases with irreversible pathology will be excluded from this study.
  • Female cases those are having pregnancy will be excluded.
  • The cases which do not match with symptoms of constitution chapter, e.g. Local disease, one sided disease.
  • Patients not taking medicine as per directions.

结局指标

主要结局

Monarch score

时间窗: At first follow up which will be at 2 weeks and at the end of treatment

次要结局

  • FBS,PP2BS,HBA1C(At the beginning of treatment, at the end of 3 months and 6 months)

研究者

发起方
Dr Renuben Chavda
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Meera Shah

Dr V H Dave Homoeopathic Medical College

研究点 (1)

Loading locations...

相似试验